There is no record of Denmark announcing the tariff on Ozempic exports. The social media user who first shared the claim ...

AbbVie’s Skyrizi was responsible for the highest TV advertising outlay in pharma in most months of 2024, but 2025 is starting ...

Telehealth company Hims & Hers' first Super Bowl ad is provocative and effective in building awareness of its weight loss ...

Telehealth company Him & Hers Health is taking a very different approach to its Super Bowl ad this year - as its new ...

American host and television producer Oprah Winfrey recently shared her initial experience of taking the weight loss drug GLP ...

LBC can reveal the Advertising Standards Authority issued a warning to a weight loss treatment provider over an advert which ...

A new poll from The Associated Press-NORC Center for Public Affairs Research shows about half of U.S. adults believe it is a ...

Donald Trump is executing a shock and awe strategy, burying the public in a smoky cloud of flamboyant proposals. Some, like ...

Australia's agriculture sector is poised for a strong year, but the Trump presidency, global conflicts and anti-obesity ...

We came across a bullish thesis on Novo Nordisk A/S (NVO) on Long-Term Pick’s Substack by Dan. In this article, we will summarize the bulls’ thesis on NVO.

Wegovy is a GLP-1 agonist containing semaglutide, the same active ingredient as Ozempic. While both medications share this ...

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.